Liquidia (LQDA) Cost of Revenue (2020 - 2026)
Liquidia (LQDA) posted quarterly Cost of Revenue of $11.1 million for Q1 2026, up 630.32% year-over-year from $1.5 million in Q1 2025, and up 115.67% quarter-over-quarter from $5.1 million in Q4 2025.
Liquidia (LQDA) Cost of Revenue (2020 - 2026) Analysis & Trends
Liquidia's Cost of Revenue history runs 7 years deep, the most recent figure standing at $11.1 million for Q1 2026.
- In Q1 2026, Cost of Revenue rose 630.32% year-over-year to $11.1 million; the TTM figure through Mar 2026 stood at $19.8 million (up 234.0% YoY), while the FY2025 annual figure was $8.8 million, up 50.09% from the prior year.
- Cost of Revenue for Q1 2026 stood at $11.1 million, up from $5.1 million in the prior quarter.
- The five-year high for Cost of Revenue was $11.1 million in Q1 2026, with the low at $570000.0 in Q3 2023.
- The 5-year median for Cost of Revenue is $1.3 million (2025), against an average of $1.9 million.
- The sharpest annual moves came in 2023 and 2026: Cost of Revenue dropped 22.97% in 2023, then soared 630.32% in 2026.
- Liquidia's Cost of Revenue stood at $694000.0 in 2022, then surged by 43.08% to $993000.0 in 2023, then soared by 36.35% to $1.4 million in 2024, then surged by 279.39% to $5.1 million in 2025, then surged by 115.67% to $11.1 million in 2026.
- Business Quant data shows LQDA's Cost of Revenue at $11.1 million in Q1 2026, $5.1 million in Q4 2025, and $2.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Liquidia | 6.49 Bn | 6.21 Bn | 160.92 Mn | 10.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.76 Mn |
| Jun 30, 2026 | 10.76 Mn |
| Mar 31, 2026 | 11.08 Mn |
| Mar 31, 2026 | 11.08 Mn |
| Dec 31, 2025 | 5.14 Mn |
| Dec 31, 2025 | 5.14 Mn |
| Sep 30, 2025 | 2.30 Mn |
| Sep 30, 2025 | 2.30 Mn |
| Jun 30, 2025 | 1.29 Mn |
| Jun 30, 2025 | 1.29 Mn |
| Mar 31, 2025 | 1.52 Mn |
| Mar 31, 2025 | 1.52 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Mar 31, 2024 | 1.47 Mn |
| Mar 31, 2024 | 1.47 Mn |